Satralizumab Treatment in Adult Patients with AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Switching From Other Therapies: A Case Series

Update Item Information
Identifier 20230312_nanos_posters_058
Title Satralizumab Treatment in Adult Patients with AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Switching From Other Therapies: A Case Series
Creator Hesham Abboud; Brian Steingo; Diana Vargas; Julie Patel; Nancy Nealon; Mary Alissa Willis; Dmitry Khaitov; Jose Avila Ornelas; Adnan Subei; Lisa Ferayorni; Xavier Laucirica; Shervin Gholizadeh
Affiliation (HA) University Hospitals Cleveland Medical Center; (BS) Infinity Clinical Research; (DV) Emory University School of Medicine; (JP) Emory University School of Medicine and Emory University Hospital Midtown; (NN) Weill Cornell Medicine; (MAW) University of Mississippi Medical Center; (DK) Lehigh Valley Health Network; (JAO) HIMA Caguas Multiple Sclerosis Center; (AS) Memorial Healthcare System; (LF) (XL) (SG) Genentech, Inc.
Subject Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid)
Description The US FDA approved satralizumab for use in adult patients with aquaporin 4 autoantibody-positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) in 2020, but real-world data are limited. The objective of this case series is to describe the response to satralizumab in adult patients with AQP4-IgG+ NMOSD who previously received biologic or nonbiologic NMOSD treatment in clinical practice.
Date 2023-03-14
Language eng
Format application/pdf
Type Text
Source 2023 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2023: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s69hqg3w
Setname ehsl_novel_nam
ID 2335264
Reference URL https://collections.lib.utah.edu/ark:/87278/s69hqg3w
Back to Search Results